Multifocal motor neuropathy (MMN) is a rare, clinically well-defined condition within the spectrum of chronic, immune-mediated neuropathies. A typical patient history involves slowly or stepwise progressive, predominantly distal, asymmetrical limb weakness and muscle wasting, most frequently in the arm, that may have developed over a period of years. As a rare condition, MMN may present a diagnostic challenge for non-specialists and some patients may wait years for a correct diagnosis. Timely and accurate diagnosis is essential for patients with MMN. Unlike some motor neuropathies, MMN is treatable with intravenous immunoglobulin and untreated patients are likely to experience progressive muscle weakness that may result in serious functional impairment and impaired quality of life. The aim of this article is therefore to provide a guide for non-specialist neurologists to the clinical recognition and differential diagnosis of MMN.
for the diagnosis, but sensory symptoms such as paraesthesia or numbness may occasionally develop over the course of the disease.
It is therefore advisable not to rule out a diagnosis of MMN in patients with sensory symptoms, if objective sensory abnormalities are absent.
Tendon reflexes are usually diminished or absent in the territory of the affected nerve. Normal or slightly increased or brisk tendon reflexes have, however, been reported 6 and do not exclude a diagnosis of MMN if there are no upper motor neurone signs. Cranial nerve involvement is uncommon.
Investigations

Nerve Conduction Studies
Although it is theoretically possible to diagnose MMN in some patients on the basis of their clinical presentation alone, the hallmark of MMN is the presence of conduction block (CB) in motor, but not sensory, nerve fibres that do not involve common compression sites. 18 CB is defined as the failure of action potential propagation at a given site of a single axon. Some relatively simple electrophysiological techniques that can be used to diagnose CB in MMN by neurologists trained in nerve conduction studies are outlined elsewhere in this supplement.
Electrophysiological investigation may show a combination of motor CB and slowing of motor conduction consistent with demyelination, but with normal sensory conduction. Apart from decreased distal compound muscle action potentials (CMAP), other signs of motor axon loss include fibrillations at rest and a neurogenic pattern at full muscle contraction on needle electromyography (EMG). 18, 19 There has been some debate on the degree of CMAP necessary to define definite, probable or possible CB. The evidence remains limited, but recently revised European guidelines include consensus good practice points that provide electrophysiological diagnostic criteria for CB (see Table 2 ).
Nerve conduction studies in the nerves with motor abnormalities play an essential role in distinguishing MMN from other disorders with a similar clinical presentation. However, some patients present with
Clinical Differential Diagnosis of Multifocal Motor Neuropathy A full routine biochemistry was performed, including full blood counts, thyroid function tests, blood glucose, serum vitamin B12
and folate, and immunofixation looking for a monoclonal peak.
Serum antibody reactivity against anti-myelin-associated (MAG) activity and ganglosides GM1, GM2, GM3, GD1a, GD1b, GT1b,
GQ1b, GD3, was tested by ELISA assay and the titres compared to those of controls. Anti-GM1 antibodies were 1:200, limit of normal: 1:100, while other results were normal. The diagnosis of multifocal motor neuropathy (MMN) was then assessed. • Negative CMAP amplitude on stimulation of the distal part of the segment with motor conduction block must be >20 % of the lower limit of normal and >1 mV
• Increase of proximal to distal negative peak CMAP must be duration ≤30 % 2 Probable Motor Conduction Block* • Negative peak CMAP area reduction of at least 30 % over a long segment (e.g. wrist to elbow or elbow to axial) of an upper limb nerve with an increase of proximal to distal negative peak CMAP duration ≤30 % or:
• Negative CMAP area reduction of at least 50 % (same as definite) with an increase of proximal negative CMAP duration of >30 % Multifocal Motor Neuropathy The algorithm shown in Figure 1 is intended to help in avoiding some common pitfalls in differential diagnosis. 
Conclusion
